genomicspersonalized medicineprecision oncologypharmacogenomics
Genomics and the Future of Personalized Medicine
2023-09-28 · 8 min read
From Genes to Drugs
Personalized medicine is revolutionizing care by leveraging genomic data to tailor treatments. Whether it's cancer therapy or antidepressant selection, your DNA now plays a starring role in medical decisions.
"Whole genome sequencing costs have dropped from $100M in 2001 to under $200 today, enabling routine clinical use (NHGRI 2023)."
Clinical Applications
- Oncology:
- PARP inhibitors for BRCA+ cancers improve 5-year survival by 42%
- FoundationOne CDx tests 324 cancer genes to guide therapy
- Pharmacogenomics:
- CYP2C19 testing prevents clopidogrel resistance in 30% of PCI patients
- HLA-B*57:01 screening reduces abacavir hypersensitivity by 100%
- Preventive Care:
- APOE4 detection enables early Alzheimer's interventions
- 23andMe identifies BRCA mutations with 99% concordance to clinical tests
Technical Advances
- Sequencing:
- Oxford Nanopore provides real-time sequencing in <4 hours
- CRISPR-based diagnostics (SHERLOCK) detect SNPs at point-of-care
- Analysis:
- AI interprets VUS (variants of unknown significance) with 89% accuracy
- Polygenic risk scores combine 1M+ SNPs for disease prediction
Implementation Challenges
- Insurance coverage for genomic testing varies widely
- Data privacy concerns with cloud-based analysis
- Clinical interpretation bottlenecks (avg. 3 week wait for results)